GLP-1 drugs are now friendlier to needle-phobes. But do the pills still work?

The enormous popularity of new weight-loss drugs often eclipses the downsides: the burden of weekly injections, rough ...

For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss.

If you’re weighing the option of Wegovy versus Zepbound for weight loss, here’s how the two medications compare in terms of effectiveness, side effects, average costs and the best online weight loss ...

The weekly injection is now the first drug treatment option cleared for patients with obesity and moderate-to-severe obstructive sleep apnea, or OSA, which refers to breathing interrupted during sleep ...

Zepbound and Wegovy treat weight loss and weight management in adults with obesity or overweight. Both drugs are also approved to treat other conditions. These drugs are given as weekly injections, ...

FDA approvals of Novo Nordisk's oral Wegovy and Eli Lilly's Foundayo have introduced needle-free obesity treatments, offering ...

A trial was conducted comparing weight loss medications Zepbound and Wegovy. Results from the trial found that participants who took Zepbound lost more weight than those who took Wegovy. Side effects ...

Headache wasn’t reported as a side effect in Zepbound’s studies. But, it may be a symptom of some of Zepbound’s side effects. More common side effects of Zepbound are digestive side effects, such as ...

Zepbound and Ozempic are both prescription drugs part of the GLP-1 agonist drug class. While their uses are different, they do have some similarities, such as dosing schedule and form. This article ...

Mounjaro and Zepbound are two brand-name glucagon-like peptide-1 (GLP-1) medications manufactured by Eli Lilly. Although they contain the same active ingredient, tirzepatide, and may affect blood ...